Narasimhan Mani

Narasimhan Mani is recorded as CFO at Scienture Holdings, Inc. (SCNX) since May 26, 2026, CEO at Scienture Holdings, Inc. (SCNX) since May 20, 2025 and Board Member at Scienture Holdings, Inc. (SCNX) since May 28, 2024. The newest filing on record that lists Narasimhan Mani as Board Member at Scienture Holdings, Inc. (SCNX) is dated September 18, 2026. Scienture Holdings, Inc. reported in an 8-K filed May 22, 2025 that Narasimhan Mani was appointed President, effective May 20, 2025. Scienture Holdings, Inc. reported in an 8-K filed May 22, 2025 that Narasimhan Mani was appointed director, effective May 20, 2025. Scienture Holdings, Inc. reported in an 8-K filed May 22, 2025 that Narasimhan Mani was appointed co-Chief Executive Officer, effective May 20, 2025. Equibles holds 7 filed executive changes naming Narasimhan Mani; each is listed under recent activity with its source filing. Scienture Holdings, Inc. is classified in the Pharmaceutical Retailers industry within the Healthcare sector. Other leadership on record at Scienture Holdings, Inc. includes Dr. Narasimhan Mani (CEO, CFO and Board Member), Dr. Shankar Hariharan (CEO and Chairman), Shankar Hariharan (CEO, Chairman and Board Member) and 7 others.